Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (11) , 1578-1583
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
This publication has 37 references indexed in Scilit:
- Gene Sequencing for Routine Verification of Pyrazinamide Resistance in Mycobacterium tuberculosis: a Role for pncA but Not rpsAJournal of Clinical Microbiology, 2012
- Molecular Characterization of Multidrug-Resistant Mycobacterium tuberculosis Isolated in NepalAntimicrobial Agents and Chemotherapy, 2012
- Mutation Analysis of Mycobacterial rpoB Genes and Rifampin Resistance Using Recombinant Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 2012
- Minimal inhibitory concentrations of first-line drugs of multidrug -resistant tuberculosis isolatesLung India, 2012
- Novel Mycobacterium tuberculosis Complex Pathogen, M. mungiEmerging Infectious Diseases, 2010
- A Balancing Act: Efflux/Influx in Mycobacterial Drug ResistanceAntimicrobial Agents and Chemotherapy, 2009
- Tuberculosis Drug Resistance Mutation DatabasePLOS Medicine, 2009
- Newly Developed Primers for Comprehensive Amplification of the rpoB Gene and Detection of Rifampin Resistance in Mycobacterium tuberculosisJournal of Clinical Microbiology, 2007
- rpoB Gene Mutations and Molecular Characterization of Rifampin-Resistant Mycobacterium tuberculosis Isolates from Shandong Province, ChinaJournal of Clinical Microbiology, 2006
- Molecular Characterization of Multidrug-Resistant Isolates of Mycobacterium tuberculosis from Patients in North IndiaAntimicrobial Agents and Chemotherapy, 2002